Understanding the spread of drug-resistant infections in nursing homes
Epidemiology of MDRO Carriage in Nursing Homes
This study is looking at how common and serious drug-resistant infections are in nursing homes, where they happen more often than in hospitals, to help create better ways to keep residents safe and healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11119000 on NIH RePORTER |
What this research studies
This research investigates the prevalence and impact of multidrug-resistant organisms (MDROs) in nursing homes, where these infections are more common than in hospitals. It aims to assess the health outcomes associated with MDRO carriage among residents, focusing on five significant pathogens, including MRSA and Candida auris. By analyzing the unique conditions of nursing homes, such as long stays and shared spaces, the study seeks to develop tailored strategies for infection prevention and control. The findings will help create guidelines to reduce MDROs and improve patient safety in these vulnerable settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are residents of nursing homes who may be at risk for multidrug-resistant infections.
Not a fit: Patients who are not in nursing homes or those who do not have risk factors for MDRO infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved infection control practices in nursing homes, ultimately reducing the incidence of drug-resistant infections among residents.
How similar studies have performed: Previous research has shown success in addressing MDROs in hospital settings, but this approach in nursing homes is relatively novel and untested.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Huang, Susan S. — University of California-Irvine
- Study coordinator: Huang, Susan S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.